※ PTMD 2.0 database Online Browse Options
Browse result for Cardiovascular phenotype
※ introduction Cardiovascular disease (CVD) is any disease involving the heart or blood vessels. CVDs constitute a class of diseases that includes: coronary artery diseases (e.g. angina, heart attack), heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.
The underlying mechanisms vary depending on the disease. It is estimated that dietary risk factors are associated with 53% of CVD deaths. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes mellitus, lack of exercise, obesity, high blood cholesterol, poor diet, excessive alcohol consumption, and poor sleep, among other things. High blood pressure is estimated to account for approximately 13% of CVD deaths, while tobacco accounts for 9%, diabetes 6%, lack of exercise 6%, and obesity 5%. Rheumatic heart disease may follow untreated strep throat.
It is estimated that up to 90% of CVD may be preventable. Prevention of CVD involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people who are otherwise healthy is of unclear benefit.
Cardiovascular diseases are the leading cause of death worldwide except Africa. Together CVD resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80, while it is around 68 in the developing world. CVD is typically diagnosed seven to ten years earlier in men than in women.:?48?
Reference
Wiki: Cardiovascular phenotype
Reference
Wiki: Cardiovascular phenotype
| PTMD ID | UniProt Accession | Entrez ID | Gene Name | Protein Name | Organism |
|---|---|---|---|---|---|
| PTMD00154 | O95677 | 2070 | EYA4 | Eyes absent homolog 4 | Homo sapiens |
| PTMD00500 | P02545 | 4000 | LMNA | Prelamin-A/C [Cleaved into: Lamin-A/C ] | Homo sapiens |
| PTMD00305 | P04049 | 5894 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens |
| PTMD00518 | P08590 | 4634 | MYL3 | Myosin light chain 3 | Homo sapiens |
| PTMD00243 | P13473 | 3920 | LAMP2 | Lysosome-associated membrane glycoprotein 2 | Homo sapiens |
| PTMD00540 | P14923 | 3728 | JUP | Junction plakoglobin | Homo sapiens |
| PTMD00896 | P18206 | 7414 | VCL | Vinculin | Homo sapiens |
| PTMD00556 | P21333 | 2316 | FLNA | Filamin-A | Homo sapiens |
| PTMD00588 | P36897 | 7046 | TGFBR1 | TGF-beta receptor type-1 | Homo sapiens |
| PTMD00254 | P37173 | 7048 | TGFBR2 | TGF-beta receptor type-2 | Homo sapiens |
| PTMD00179 | P46531 | 4851 | NOTCH1 | Neurogenic locus notch homolog protein 1 [Cleaved into: Notch 1 extracellular truncation ; Notch 1 intracellular domain ] | Homo sapiens |
| PTMD00252 | P84022 | 4088 | SMAD3 | Mothers against decapentaplegic homolog 3 | Homo sapiens |
| PTMD00665 | Q0ZGT2 | 91624 | NEXN | Nexilin | Homo sapiens |
| PTMD00147 | Q13485 | 4089 | SMAD4 | Mothers against decapentaplegic homolog 4 | Homo sapiens |
| PTMD00700 | Q15746 | 4638 | MYLK | Myosin light chain kinase, smooth muscle [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] | Homo sapiens |
| PTMD00924 | Q16595 | 2395 | FXN | Frataxin, mitochondrial [Cleaved into: Frataxin intermediate form ; Frataxin ; Frataxin ; Frataxin mature form ) ; Extramitochondrial frataxin] | Homo sapiens |
| PTMD00051 | Q16635 | 6901 | TAFAZZIN | Tafazzin | Homo sapiens |
| PTMD02221 | E7EWK1 | 10587 | TXNRD2 | Thioredoxin reductase 2 | Homo sapiens |
| PTMD01461 | P02511 | 1410 | CRYAB | Alpha-crystallin B chain -crystallin) | Homo sapiens |
| PTMD01064 | P09493 | 7168 | TPM1 | Tropomyosin alpha-1 chain | Homo sapiens |
| PTMD01525 | P15924 | 1832 | DSP | Desmoplakin | Homo sapiens |
| PTMD01606 | P35555 | 2200 | FBN1 | Fibrillin-1 [Cleaved into: Asprosin] | Homo sapiens |
| PTMD01694 | P68032 | 70 | ACTC1 | Actin, alpha cardiac muscle 1 [Cleaved into: Actin, alpha cardiac muscle 1, intermediate form] | Homo sapiens |
| PTMD01733 | Q12809 | 3757 | KCNH2 | Potassium voltage-gated channel subfamily H member 2 | Homo sapiens |
| PTMD01751 | Q14524 | 6331 | SCN5A | Sodium channel protein type 5 subunit alpha | Homo sapiens |
| PTMD01131 | Q14896 | 4607 | MYBPC3 | Myosin-binding protein C, cardiac-type | Homo sapiens |
| PTMD01845 | Q8WZ42 | 7273 | TTN | Titin | Homo sapiens |
| PTMD01162 | Q92736 | 6262 | RYR2 | Ryanodine receptor 2 | Homo sapiens |
| PTMD01878 | Q9BR39 | 57158 | JPH2 | Junctophilin-2 [Cleaved into: Junctophilin-2 N-terminal fragment ] | Homo sapiens |
| PTMD02978 | O60939 | 6327 | SCN2B | Sodium channel subunit beta-2 | Homo sapiens |
| PTMD03005 | O75112 | 11155 | LDB3 | LIM domain-binding protein 3 | Homo sapiens |
| PTMD03465 | O95528 | 81031 | SLC2A10 | Solute carrier family 2, facilitated glucose transporter member 10 | Homo sapiens |
| PTMD03789 | P06280 | 2717 | GLA | Alpha-galactosidase A | Homo sapiens |
| PTMD04056 | P10916 | 4633 | MYL2 | Myosin regulatory light chain 2, ventricular/cardiac muscle isoform | Homo sapiens |
| PTMD04088 | P11532 | 1756 | DMD | Dystrophin | Homo sapiens |
| PTMD04124 | P12755 | 6497 | SKI | Ski oncogene | Homo sapiens |
| PTMD04130 | P12883 | 4625 | MYH7 | Myosin-7 | Homo sapiens |
| PTMD04145 | P13533 | 4624 | MYH6 | Myosin-6 | Homo sapiens |
| PTMD04456 | P20908 | 1289 | COL5A1 | Collagen alpha-1 chain | Homo sapiens |
| PTMD04933 | P35520 | 10272 | CBS | Cystathionine beta-synthase | Homo sapiens |
| PTMD04938 | P35556 | 2201 | FBN2 | Fibrillin-2 [Cleaved into: Placensin] | Homo sapiens |
| PTMD04944 | P35609 | 88 | ACTN2 | Alpha-actinin-2 | Homo sapiens |
| PTMD04957 | P35749 | 4629 | MYH11 | Myosin-11 | Homo sapiens |
| PTMD05083 | P42166 | 7112 | TMPO | Lamina-associated polypeptide 2, isoform alpha [Cleaved into: Thymopoietin ; Thymopentin ] | Homo sapiens |
| PTMD05377 | P50402 | 2010 | EMD | Emerin | Homo sapiens |
| PTMD05384 | P50461 | 8048 | CSRP3 | Cysteine and glycine-rich protein 3 | Homo sapiens |
| PTMD05456 | P51787 | 3784 | KCNQ1 | Potassium voltage-gated channel subfamily KQT member 1 | Homo sapiens |
| PTMD05493 | P52179 | 8736 | MYOM1 | Myomesin-1 | Homo sapiens |
| PTMD05876 | P62736 | 59 | ACTA2 | Actin, aortic smooth muscle [Cleaved into: Actin, aortic smooth muscle, intermediate form] | Homo sapiens |
| PTMD06110 | Q01484 | 287 | ANK2 | Ankyrin-2 | Homo sapiens |
| PTMD06160 | Q02487 | 1824 | DSC2 | Desmocollin-2 | Homo sapiens |
| PTMD06169 | Q02809 | 5351 | PLOD1 | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | Homo sapiens |
| PTMD06443 | Q13061 | 10345 | TRDN | Triadin | Homo sapiens |
| PTMD06532 | Q13418 | 3611 | ILK | Integrin-linked protein kinase | Homo sapiens |
| PTMD06654 | Q13976 | 5592 | PRKG1 | cGMP-dependent protein kinase 1 | Homo sapiens |
| PTMD06676 | Q14126 | 1829 | DSG2 | Desmoglein-2 | Homo sapiens |
| PTMD06937 | Q15327 | 27063 | ANKRD1 | Ankyrin repeat domain-containing protein 1 | Homo sapiens |
| PTMD07043 | Q15842 | 3764 | KCNJ8 | ATP-sensitive inward rectifier potassium channel 8 channel Kir6.1) | Homo sapiens |
| PTMD07079 | Q16363 | 3910 | LAMA4 | Laminin subunit alpha-4 | Homo sapiens |
| PTMD07741 | Q5T481 | 28299 | RBM20 | RNA-binding protein 20 | Homo sapiens |
| PTMD08964 | Q86TC9 | 84665 | MYPN | Myopalladin | Homo sapiens |
| PTMD09624 | Q8N335 | 23171 | GPD1L | Glycerol-3-phosphate dehydrogenase 1-like protein | Homo sapiens |
| PTMD10363 | Q8TD43 | 54795 | TRPM4 | Transient receptor potential cation channel subfamily M member 4 | Homo sapiens |
| PTMD10882 | Q93074 | 9968 | MED12 | Mediator of RNA polymerase II transcription subunit 12 | Homo sapiens |
| PTMD11843 | Q99593 | 6910 | TBX5 | T-box transcription factor TBX5 | Homo sapiens |
| PTMD11923 | Q99959 | 5318 | PKP2 | Plakophilin-2 | Homo sapiens |
| PTMD12114 | Q9BTV4 | 79188 | TMEM43 | Transmembrane protein 43 | Homo sapiens |
| PTMD14271 | Q9UK17 | 3752 | KCND3 | Potassium voltage-gated channel subfamily D member 3 | Homo sapiens |
| PTMD14458 | Q9UMR3 | 57057 | TBX20 | T-box transcription factor TBX20 | Homo sapiens |
| PTMD14801 | Q9Y3Q4 | 10021 | HCN4 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Homo sapiens |
